Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: A multicenter placebo-controlled study
- 1 February 1993
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 104 (2), 435-439
- https://doi.org/10.1016/0016-5085(93)90411-5
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Mesalazine: A Global Safety EvaluationScandinavian Journal of Gastroenterology, 1990
- Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.Gut, 1988
- 5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®Scandinavian Journal of Gastroenterology, 1987
- Effect of a Slow-Release 5´-Aminosalicylic Acid Preparation on Disease Activity in Crohn’s DiseaseDigestion, 1986
- Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study.Gut, 1981
- The Long-term Prophylactic Effect of Salazosulfapyridine (SalazopyrinR) in Primarily Resected Patients with Crohn's DiseaseScandinavian Journal of Gastroenterology, 1978
- Nephrotoxic Lesions from 5-Aminosalicylic AcidBMJ, 1972
- Recurrence of Crohn's disease after primary excisional surgeryGut, 1971
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958